• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质厌食症综合征的动物模型。

Animal models of the cancer anorexia-cachexia syndrome.

机构信息

Section of Palliative Medicine and Suppportive Oncology, The Cleveland Clinic Taussig Cancer Center, Cleveland, OH 44195, USA.

出版信息

Support Care Cancer. 2011 Sep;19(9):1451-63. doi: 10.1007/s00520-010-0972-0. Epub 2010 Aug 17.

DOI:10.1007/s00520-010-0972-0
PMID:20714754
Abstract

BACKGROUND AND AIMS

Cancer cachexia, a complex wasting syndrome, is common in palliative medicine. Animal models expand our understanding of its mechanisms. A review of cancer cachexia and anorexia animal models will help investigators make an informed choice of the study model.

RESULTS AND DISCUSSION

Cancer-anorexia cachexia animal models are numerous. No one is ideal. The choice should depend on the research question. To investigate cancer-anorexia cachexia independent of pro-inflammatory cytokine effects, the MAC16 ADK and XK1 are useful. MAC16 ADK helps study the host's tumor metabolic effects, independent of any anorexia or inflammation. XK1 is both anorectic and cachectic, but data about it is limited. All other models induce a host inflammatory response. The Walker 256 ADK and MCG 101 are best avoided due to excessive tumor growth. Since individual models do not address all aspects of the syndrome, use of a combination seems wise. Suggested combinations: MAC16-ADK (non-inflammatory and non-anorectic) with YAH-130 (inflammatory, anorectic, and cachectic), Lewis lung carcinoma (slow onset anorexia) or prostate adenocarcinoma (inflammatory, anorectic but not cachectic) with YAH-130.

摘要

背景与目的

癌症恶病质是一种复杂的消耗性综合征,在姑息医学中很常见。动物模型扩展了我们对其机制的理解。对癌症恶病质和厌食症动物模型的综述将帮助研究人员在研究模型中做出明智的选择。

结果与讨论

癌症-厌食-恶病质动物模型很多。没有一个是理想的。选择应取决于研究问题。为了研究与促炎细胞因子作用无关的癌症-厌食-恶病质,MAC16 ADK 和 XK1 很有用。MAC16 ADK 有助于研究宿主的肿瘤代谢效应,而与任何厌食或炎症无关。XK1 既厌食又恶病质,但关于它的数据有限。所有其他模型都会引起宿主的炎症反应。由于肿瘤生长过度,Walker 256 ADK 和 MCG 101 最好避免使用。由于单个模型不能解决该综合征的所有方面,因此似乎明智的是使用组合。建议的组合:MAC16-ADK(非炎症性和非厌食性)与 YAH-130(炎症性、厌食性和恶病质性),Lewis 肺癌(发病缓慢的厌食症)或前列腺腺癌(炎症性、厌食性但不恶病质)与 YAH-130。

相似文献

1
Animal models of the cancer anorexia-cachexia syndrome.癌症恶病质厌食症综合征的动物模型。
Support Care Cancer. 2011 Sep;19(9):1451-63. doi: 10.1007/s00520-010-0972-0. Epub 2010 Aug 17.
2
Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.导致恶病质-厌食综合征的中枢神经系统机制。
Nutrition. 2000 Oct;16(10):1009-12. doi: 10.1016/s0899-9007(00)00413-5.
3
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides.癌症恶病质综合征:细胞因子与神经肽
Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):427-34. doi: 10.1097/01.mco.0000134363.53782.cb.
4
Cytokines and cancer anorexia cachexia syndrome.细胞因子与癌症恶病质综合征
Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10.
5
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.治疗洞察:癌症恶病质综合征——当你只能消耗自身时。
Nat Clin Pract Oncol. 2005 Mar;2(3):158-65. doi: 10.1038/ncponc0112.
6
[Recent development in research and management of cancer anorexia-cachexia syndrome].[癌症恶病质综合征的研究与管理新进展]
Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9.
7
Cachexia and anorexia in malignancy.恶性肿瘤中的恶病质和厌食症。
Hematol Oncol Clin North Am. 1996 Aug;10(4):791-800. doi: 10.1016/s0889-8588(05)70368-3.
8
Anorexia and cachexia in advanced cancer.晚期癌症中的厌食和恶病质。
Nurs Clin North Am. 2001 Dec;36(4):735-44, vii.
9
[Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].[医学中与喂养相关的疾病,特别提及癌症恶病质综合征]
Rinsho Byori. 2006 Oct;54(10):1044-51.
10
Cachexia and anorexia: cancer's covert killer.恶病质与厌食症:癌症的隐匿杀手。
Support Care Cancer. 2000 May;8(3):180-7. doi: 10.1007/s005200050282.

引用本文的文献

1
Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational Study.非小细胞肺癌患者服用贝特类药物后肌肉损失减少:一项回顾性观察研究的结果
J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70016. doi: 10.1002/jcsm.70016.
2
Modulating the Gut-Muscle Axis: Increasing SCFA-Producing Gut Microbiota Commensals and Decreasing Endotoxin Production to Mitigate Cancer Cachexia.调节肠-肌轴:增加产生短链脂肪酸的肠道微生物共生菌并减少内毒素产生以减轻癌症恶病质。
Microorganisms. 2025 Jun 11;13(6):1356. doi: 10.3390/microorganisms13061356.
3
Cell-death induced immune response and coagulopathy promote cachexia in .

本文引用的文献

1
The past, present and future of multi-targeted cancer treatment "naturally": food for thought.
Cancer Lett. 2008 Oct 8;269(2):187-8. doi: 10.1016/j.canlet.2008.04.007. Epub 2008 May 27.
2
Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.Walker荷瘤大鼠的蛋白水解诱导因子在C2C12肌管中引起的代谢和形态学改变。
BMC Cancer. 2008 Jan 28;8:24. doi: 10.1186/1471-2407-8-24.
3
Comparison of animal models for head and neck cancer cachexia.头颈部癌恶病质动物模型的比较
细胞死亡诱导的免疫反应和凝血病促进了……中的恶病质。 (注:原文句子不完整,缺少具体所指对象)
bioRxiv. 2025 Feb 10:2025.01.07.631515. doi: 10.1101/2025.01.07.631515.
4
Early adipose tissue wasting in a novel preclinical model of human lung cancer cachexia.人类肺癌恶病质新型临床前模型中的早期脂肪组织消耗
bioRxiv. 2025 Jul 1:2024.09.27.615385. doi: 10.1101/2024.09.27.615385.
5
Metabolic, Inflammatory, and Molecular Impact of Cancer Cachexia on the Liver.癌症恶病质对肝脏的代谢、炎症和分子影响。
Int J Mol Sci. 2024 Nov 7;25(22):11945. doi: 10.3390/ijms252211945.
6
Cancer cachexia: multilevel metabolic dysfunction.癌症恶病质:多级代谢功能障碍。
Nat Metab. 2024 Dec;6(12):2222-2245. doi: 10.1038/s42255-024-01167-9. Epub 2024 Nov 22.
7
A comprehensive review of animal models for cancer cachexia: Implications for translational research.癌症恶病质动物模型的全面综述:对转化研究的启示
Genes Dis. 2023 Sep 13;11(6):101080. doi: 10.1016/j.gendis.2023.101080. eCollection 2024 Nov.
8
Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration.通过跨学科合作确定并解决癌症恶病质的研究重点
Cancers (Basel). 2024 Jun 27;16(13):2364. doi: 10.3390/cancers16132364.
9
OBSERVE: guidelines for the refinement of rodent cancer models.注意:啮齿类动物癌症模型改良指南。
Nat Protoc. 2024 Sep;19(9):2571-2596. doi: 10.1038/s41596-024-00998-w. Epub 2024 Jul 11.
10
AMPK as a mediator of tissue preservation: time for a shift in dogma?AMPK 作为组织保存的中介:改变观念的时候到了?
Nat Rev Endocrinol. 2024 Sep;20(9):526-540. doi: 10.1038/s41574-024-00992-y. Epub 2024 May 17.
Laryngoscope. 2007 Dec;117(12):2152-8. doi: 10.1097/MLG.0b013e3181453658.
4
Murine models to evaluate novel and conventional therapeutic strategies for cancer.用于评估癌症新型和传统治疗策略的小鼠模型。
Am J Pathol. 2007 Mar;170(3):793-804. doi: 10.2353/ajpath.2007.060929.
5
Comparison of treatment effects between animal experiments and clinical trials: systematic review.动物实验与临床试验治疗效果的比较:系统评价
BMJ. 2007 Jan 27;334(7586):197. doi: 10.1136/bmj.39048.407928.BE. Epub 2006 Dec 15.
6
The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms.癌症化疗药物依托泊苷(VP - 16)在癌症化疗相关症状的小鼠模型中诱导促炎细胞因子产生和类似疾病行为的症状。
Biol Res Nurs. 2006 Oct;8(2):157-69. doi: 10.1177/1099800406290932.
7
Early satiety in cancer patients: a common and important but underrecognized symptom.癌症患者的早饱:一种常见且重要但未得到充分认识的症状。
Support Care Cancer. 2006 Jul;14(7):693-8. doi: 10.1007/s00520-005-0015-4. Epub 2006 Apr 20.
8
From bedside to bench and back again: research issues in animal models of human disease.从床边到实验台再回归床边:人类疾病动物模型的研究问题
Biol Res Nurs. 2006 Jul;8(1):78-88. doi: 10.1177/1099800406289717.
9
ON THE CONDITIONS OF ELICITATION OF CERTAIN EATING REFLEXES.论某些进食反射的引发条件。
Proc Natl Acad Sci U S A. 1930 Jun 15;16(6):433-8. doi: 10.1073/pnas.16.6.433.
10
Ratio of n6 to n-3 fatty acids in the diet affects tumor growth and cachexia in Walker 256 tumor-bearing rats.饮食中n6与n-3脂肪酸的比例会影响荷Walker 256肿瘤大鼠的肿瘤生长和恶病质。
Nutr Cancer. 2005;53(2):194-201. doi: 10.1207/s15327914nc5302_8.